AT333277B - Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen - Google Patents

Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen

Info

Publication number
AT333277B
AT333277B AT508673A AT508673A AT333277B AT 333277 B AT333277 B AT 333277B AT 508673 A AT508673 A AT 508673A AT 508673 A AT508673 A AT 508673A AT 333277 B AT333277 B AT 333277B
Authority
AT
Austria
Prior art keywords
quaternar
pyridines
oxides
preparation
pyridinium salts
Prior art date
Application number
AT508673A
Other languages
German (de)
English (en)
Other versions
ATA508673A (de
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ATA508673A publication Critical patent/ATA508673A/de
Application granted granted Critical
Publication of AT333277B publication Critical patent/AT333277B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT508673A 1972-06-14 1973-06-08 Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen AT333277B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26289872A 1972-06-14 1972-06-14
BE147896A BE819177R (fr) 1972-06-14 1974-08-26 Oxazolo- et thiazolopyridines

Publications (2)

Publication Number Publication Date
ATA508673A ATA508673A (de) 1976-03-15
AT333277B true AT333277B (de) 1976-11-10

Family

ID=25648082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT508673A AT333277B (de) 1972-06-14 1973-06-08 Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen

Country Status (17)

Country Link
JP (1) JPS5943475B2 (enExample)
AR (1) AR208500A1 (enExample)
AT (1) AT333277B (enExample)
AU (1) AU472528B2 (enExample)
BE (2) BE800868A (enExample)
CA (1) CA1019741A (enExample)
CS (1) CS178889B2 (enExample)
DD (1) DD105237A5 (enExample)
DE (1) DE2330109A1 (enExample)
DK (1) DK152050C (enExample)
FI (1) FI57417C (enExample)
FR (1) FR2187356B1 (enExample)
GB (1) GB1421619A (enExample)
LU (1) LU67786A1 (enExample)
NL (1) NL184836C (enExample)
SE (2) SE401675B (enExample)
ZA (1) ZA733760B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527321A1 (de) * 1975-06-19 1976-12-23 Merck & Co Inc Oxazol eckige klammer auf 4,5-b eckige klammer zu pyridine
JPS527992A (en) * 1975-07-04 1977-01-21 Merck & Co Inc Oxazolo *4*55b* pyridines
NL187021C (nl) * 1975-07-15 1991-05-01 Merck & Co Inc Werkwijze ter bereiding van een farmaceutisch preparaat met anti-inflammatoire werking, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte anti-inflammatoir werkzame 2-fenyl-oxazolo-(4,5-b)pyridinederivaten.
US4011326A (en) * 1975-07-29 1977-03-08 Merck & Co., Inc. 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents
US4753673A (en) * 1977-07-22 1988-06-28 The Dow Chemical Company Trifluoromethyl pyridinyloxyphenoxy and pyridinylthiophenoxy propanoic acids and propanols and derivatives thereof and methods of herbicidal use
EP0001473B1 (en) 1977-08-12 1988-07-27 Imperial Chemical Industries Plc Herbicidal halogenomethyl--pyridyloxy-phenoxy-alkanecarboxylic acids and derivatives, and processes of controlling unwanted plants therewith
JPS5461182A (en) * 1977-10-20 1979-05-17 Ishihara Sangyo Kaisha Ltd 2-phenoxy-5-trifluoromethylpyridine compounds
JPS5461183A (en) * 1977-10-21 1979-05-17 Ishihara Sangyo Kaisha Ltd 2-substituted-5-trifluoromethyl pyridine compounds
JPH0224818B2 (enExample) * 1978-02-15 1990-05-30 Imuperiaru Chem Ind Plc
JPS55130840U (enExample) * 1979-03-12 1980-09-16
JPS55124763A (en) * 1979-03-19 1980-09-26 Ishihara Sangyo Kaisha Ltd 5-trifluoromethyl-2-pyridone derivative
GB8333514D0 (en) * 1983-12-16 1984-01-25 Erba Farmitalia Tetrahydrothiazolo(5 4-c)pyridine derivatives
FR2652085A1 (fr) * 1989-09-20 1991-03-22 Science Organisation Nouveau procede de synthese de derives d'oxazolopyridines.
DE59711147D1 (de) * 1996-11-11 2004-01-29 Altana Pharma Ag Neue Imidazo- und Oxazolopyridine als Phosphodiesterase Inhibitoren.
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CN1332743A (zh) * 1998-06-04 2002-01-23 艾博特公司 抑制细胞粘附抗炎化合物
HK1045306A1 (zh) * 1999-06-03 2002-11-22 Abbott Laboratories 抑制细胞黏附的抗炎化合物
AU2002216649A1 (en) * 2000-10-31 2002-05-15 Lynn Bonham Benzoxazole lpaat- beta inhibitors and uses thereof
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US7855289B2 (en) * 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
ES2431050T3 (es) 2005-08-04 2013-11-22 Sirtris Pharmaceuticals, Inc. Benzotiazoles y tiazolopiridinas como moduladores de la sirtuína
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
TW200916472A (en) 2007-06-20 2009-04-16 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
CN102164598A (zh) * 2008-08-29 2011-08-24 特温蒂斯公司 用作神经系统疾病的诊断工具和治疗的丁酰胆碱酯酶配体
SG171835A1 (en) 2008-12-19 2011-07-28 Sirtris Pharmaceuticals Inc Thiazolopyridine sirtuin modulating compounds
US20120245159A1 (en) * 2009-09-30 2012-09-27 Sumitomo Chemical Company, Limited Composition and method for controlling arthropod pests
AR082974A1 (es) 2010-09-15 2013-01-23 Hoffmann La Roche Derivados de azabenzotiazol, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos para tratar enfermedades inflamatorias
WO2012086848A1 (en) * 2010-12-24 2012-06-28 Sumitomo Chemical Company, Limited Fused heterocyclic compound and use for pest control thereof
EP3160940A4 (en) * 2014-06-25 2018-05-02 Epizyme, Inc. Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
WO2016087373A1 (de) 2014-12-02 2016-06-09 Bayer Cropscience Aktiengesellschaft Bicyclische verbindungen als schädlingsbekämpfungsmittel
US10399966B2 (en) 2016-01-21 2019-09-03 University Of Washington Compounds for treatment of trypanosomes and neurological pathogens and uses thereof
CN109790132B (zh) * 2016-07-07 2024-03-05 保土谷化学工业株式会社 具有苯并唑环结构的化合物及有机电致发光元件

Also Published As

Publication number Publication date
DE2330109A1 (de) 1974-01-03
FR2187356B1 (enExample) 1977-01-28
CA1019741A (en) 1977-10-25
SE401675B (sv) 1978-05-22
GB1421619A (en) 1976-01-21
JPS5943475B2 (ja) 1984-10-22
AU472528B2 (en) 1976-05-27
ATA508673A (de) 1976-03-15
SE432767B (sv) 1984-04-16
LU67786A1 (enExample) 1973-08-16
BE819177R (fr) 1975-02-26
SE7604385L (sv) 1976-04-14
BE800868A (fr) 1973-12-13
NL7307582A (enExample) 1973-12-18
DK152050C (da) 1988-07-18
NL184836C (nl) 1989-11-16
NL184836B (nl) 1989-06-16
JPS4961195A (enExample) 1974-06-13
ZA733760B (en) 1975-01-29
DD105237A5 (enExample) 1974-04-12
FI57417C (fi) 1980-08-11
AU5651173A (en) 1974-12-05
FR2187356A1 (enExample) 1974-01-18
DK152050B (da) 1988-01-25
FI57417B (fi) 1980-04-30
AR208500A1 (es) 1977-02-15
CS178889B2 (en) 1977-10-31

Similar Documents

Publication Publication Date Title
AT333277B (de) Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen
AT351557B (de) Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1- phenoxypropanen und von deren saeureadditions- salzen
ATA288275A (de) Verfahren zur herstellung neuer pyridinderivate und ihrer n-oxide und salze
AT339301B (de) Verfahren zur herstellung von neuen pyridinderivaten und deren saureadditionssalzen
AT315842B (de) Verfahren zur Herstellung von neuen 2-Hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoäthyl)-pyridinen und von deren Säureadditionssalzen
AT330175B (de) Verfahren zur herstellung von neuen dihydropyridinpolyestern und deren salzen
AT326659B (de) Verfahren zur herstellung von neuen derivaten des 1-phenoxy-3-amino-propan-2-ols und deren säureadditionssalzen
ATA993673A (de) Verfahren zur herstellung von neuen alfa-aminoacylcephalosporinathern und deren salzen
AT327915B (de) Verfahren zur herstellung von neuen piperazinderivaten und von deren salzen
AT327167B (de) Verfahren zur herstellung von neuen 1-aminomethyl-2,2-diarylcyclopropancarbonsaureamiden und deren saureadditionssalzen und quaternaren salzen
AT327923B (de) Verfahren zur herstellung von neuen chinazolindion-verbindungen und deren salzen
ATA687073A (de) Verfahren zur herstellung von neuen 4- (beta-ureidoathyl) benzolsulfonylharnstoffen und deren salzen
AT329558B (de) Verfahren zur hersstellung von neuen 2-(2-pyridyl)-omega-phenylalkylaminen und deren saureadditionssalzen
AT321296B (de) Verfahren zur Herstellung von neuen Oxazolen und deren Salze
AT329058B (de) Verfahren zur herstellung von neuen aminoimidazoloisochinolinderivaten und deren salzen
AT321303B (de) Verfahren zur Herstellung von neuen 2-Benzoyl-3-amino-pyridin-Verbindungen und deren Salzen
AT321907B (de) Verfahren zur herstellung von neuen oxazolidinen und deren salzen
AT330174B (de) Verfahren zur herstellung neuer piperidin-derivate und von deren salzen
AT330773B (de) Verfahren zur herstellung von neuen m-dioxan-5-methylaminen und deren salzen
AT327907B (de) Verfahren zur herstellung von neuen 1,4-athano-2,3-dihydrochinolinderivaten und deren salzen
AT320648B (de) Verfahren zur Herstellung von neuen Pyridinderivaten und von deren Salzen
AT320649B (de) Verfahren zur Herstellung von neuen 2-Benzoyl-3-aminopyridin-Verbindungen und deren Salzen
ATA764775A (de) Verfahren zur herstellung von neuen 2-(2-pyridyl)-omega-phenylalkylaminen und deren saureadditionssalzen
AT323167B (de) Verfahren zur herstellung von neuen derivaten des 1-phenoxy-3-amino-propan-2-ols und deren säureadditionssalzen
ATA202575A (de) Verfahren zur herstellung von neuen 1,2,3,4-tetrahydroisochinolinen und deren salzen